Identificar signos de vida en el espacio exige una búsqueda intensa de biofirmas. Pero nunca ha sido fácil desarrollar las tecnologías necesarias para ello. Unos científicos han ideado ahora una nueva técnica para detectar biofirmas que es de tipo eléctrico …
Nueva técnica para identificar señales de vida fuera de la Tierra Read More »
Un pulpo puede curvar con destreza una parte de un tentáculo alrededor de un obstáculo, mientras otra se introduce en una pequeña grieta para agarrar un objeto. Replicar ese control local tan sofisticado en un robot blando requiere múltiples actuadores (componentes que tr …
Gran destreza de manipulación en un robot blando mediante un solo músculo artificial Read More »
Las agresiones sexuales facilitadas por drogas, como la escopolamina (popularmente conocida como burundanga), constituyen un grave problema de salud pública y forense. Esta sustancia es especialmente peligrosa debido a sus potentes efectos amnésicos, sedantes y alucinógenos, a l …
Desarrollan un dispositivo para detectar la ‘burundanga’ en bebidas en apenas 10 minutos Read More »
Hanlon, who has worked in a variety of leadership roles at Highmark during nearly three decades with the company, will be the organization’s first-ever female CEO.
The Takeda spinout showed that a high dose of solengepras can shorten the periods during which difficult Parkinson’s disease symptoms like involuntary movements and sleepiness.
Cerevance Parkinson’s drug shortens ‘off time’ in Ph. 3, paving path to FDA Read More »
Patients can view their pulmonary artery pressure readings on their phone with the CardioMEMS updates, giving them a more active role in their care.
Abbott gets FDA nod for updates to heart failure monitoring system Read More »
ArriVent BioPharma’s Phase 3 lung cancer trial was clouded by stronger-than-expected data for patients receiving chemotherapy, prompting analysts to pivot focus to a late-stage test of the tyrosine kinase inhibitor in a different type of lung cancer and to the biotech’s antibody-drug conjugate pipeline.
ArriVent sheds nearly half of value on late-stage lung cancer miss Read More »
Caribou Biosciences entered the scene in 2011 and went public in 2021. Over the course of its existence, the biotech has received funding and support from a handful of Big Pharma players, including Novartis, AbbVie and Pfizer.
Forbion participated in the November 2025 series B round of Gate Bioscience, which earlier this week inked an up to $870 million deal extension with Eli Lilly.
Biotech VC Forbion raises record $2.6B to support 30 ‘high-potential’ companies Read More »
The investment will equip Bayer to make oncology, cardiovascular and renal care ingredients and drugs.
Bayer commits $2.2B to build pharma manufacturing plant in Ohio Read More »
